TrialReader


Differential Expression and Potential Value of c-MYC in Non-Invasive and Invasive Mammary Carcinoma

NCT06357338 — Unknown, 70 participants, Marwa Mahmoud Hassan

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Differential Expression and Potential Value of c-MYC in Non-invasive and Invasive Mammary Carcinoma

RegistryNCT06357338
StatusUnknown
Study typeObservational
Enrollment70 (Estimated)
SponsorMarwa Mahmoud Hassan (Other); collaborators: Qena Oncology Center
ConditionsInvasive Breast Cancer
Interventionsno intervention (Other)
Datesstart 2024-03-19, primary completion 2025-04-01 (estimated), completion 2026-04-01 (estimated), first posted 2024-04-10, last updated 2024-04-10
Locations1 site in Egypt

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Invasive Breast Cancer All trials of no intervention

-Summary

Retrospective observational study to evaluate c-MYC expression in non invasive and invasive mammry carcinoma

Expand all sections  ·  Collapse all

+Detailed description

To correlate different levels of c-MYC expressions with variable clinical and pathological parameters of mammary carcinoma (such as patients' ages, tumor grading, staging, laterality, focality and nodal metastasis, co-existing in-situ components). This study will be carried out on archived formalin-fixed and paraffin embedded tissue blocks that were belonged to 70 women with breast lumps.

+Arms and interventions

ArmTypeInterventionsDescription
non invasive mammary carcinomaOther: no intervention35 cases with non invasive breast cancer with low and high nuclear grades and co existing microfoci of invasion
invasive mammary carcinomaOther: no intervention35 cases of invasive breast cancer undergone MRM and classify them according grading, staging and luminal subtypes
  • no intervention (Other): No intervention

+Outcome measures

Primary outcomes

  • role of c-MYC in breast cancer [1 year]: difference between expression of c-MYC in non invasive and invasive mammary carcinoma

+Eligibility

Sex: Female, ages: 15 Years to any

Inclusion Criteria:

Specimens of Modified Radical Mastectomies from breast carcinoma patients

Exclusion Criteria:

* Cases with insufficient clinical data.

  * Tissue blocks of destroyed or insufficient material, unfit for diagnosis.
  * Cases who received pre-operative chemotherapy.

+Locations (1)

FacilityCityCountryStatus
Sohag universitySohagEgypt

+Publications

  • Gao FY, Li XT, Xu K, Wang RT, Guan XX. c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment. Cell Commun Signal. 2023 Jan 31;21(1):28. doi: 10.1186/s12964-023-01043-1. PMID 36721232

+Investigators

My Notes